Disclosures for "Perspectives on Parkinson's Disease Medications: A Qualitative Study of People with Parkinson's Disease")
-
Dr. Richards has received research support from Cerevel Therapeutics.
-
Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taiho. Dr. Brown has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Patient Centered Outcomes Research Institute (PCORI). The institution of Dr. Brown has received research support from National Comprehensive Cancer Network/Pfizer. The institution of Dr. Brown has received research support from American Society of Clinical Oncology/Pfizer. The institution of Dr. Brown has received research support from Cerevel Therapeutics .
-
Dr. Johnsrud has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atlas Clarity. Dr. Johnsrud has stock in NuCara Management Group. The institution of Dr. Johnsrud has received research support from Cerevel Therapeutics.
-
Dr. Arcona has received personal compensation for serving as an employee of Cerevel. Dr. Arcona has received stock or an ownership interest from Cerevel.
-
Dr. Sasane has nothing to disclose.
-
The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
-
Dr. Feuerstein has nothing to disclose.
-
Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbive.
-
Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Oregon Federal Public Defenders Office. Dr. Talman has received personal compensation in the range of $500-$4,999 for serving as a panelist with HDSA.
-
Dr. Mantri has received personal compensation in the range of $0-$499 for serving as a Consultant for Deep Brain Innovations, LLC. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grey Matter Technology. The institution of Dr. Mantri has received research support from Cerevel Therapeutics. The institution of Dr. Mantri has received research support from Parkinson Foundation. The institution of Dr. Mantri has received research support from The Michael J Fox Foundation for Parkinson Research. Dr. Mantri has received personal compensation in the range of $500-$4,999 for serving as a Honoraria with World Parkinson Coalition.